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Biological discoveries and technological 
advancement allowing synchronous, detailed 
analyses of metabolic systems as well as sophisti-
cated informatics will soon lead to a profound 
restructuring of medical specialties. New inter-
specialty areas are generated in the modern 
magmatic scenario, areas where the clinical 
investigator and the basic scientist will eff ectively 
join forces to create a novel integrative approach 
to clinical research.
Nephrology and  Cardiology are sister spe-
cialties. The several existing international 
societies focusing on hypertension represent 
concrete proof of the eff orts by internists, neph-
rologists and cardiologists to build a common 
approach to a condition which is of core inter-
est to these medical specialties.
Chronic kidney disease (CKD) is now an 
established public health priority and, mainly 
because of the high risk for cardiovascular 
complications secondary to renal function 
loss, it represents one of the most challenging 
problems of modern medicine. The bidirec-
tional link that associates renal and cardiovas-
cular diseases and the high risk of the death 
signaled by their coexistence is at the basis 
of a new discipline aiming at making the 
borders between nephrology and cardiovas-
cular medicine even more permeable than 
before. Cardiovascular and Renal Medicine 
is a new, shared territory for clinicians and 
investigators with a prominent interest on the 
kidney-cardiovascular system interface.
To respond to the growing interest in this 
clinical research area, the European Renal 
Association–European Dialysis and Transplant 
Association (ERA–EDTA) has recently created 
an EUropean working group (WG) focusing 
on REnal and CArdiovascular Medicine 
(EURECA-m). The scope of EURECA-m 
is that of promot ing collaborations among 
European centres pursuing research in the 
overlapping area of cardiovascular and renal 
medicine. The speci fic goals of the WG 
were delineated in a paper (NDT Plus 2010; 
2: 522–525) deposited in the WEB site of 
the same WG (http://www.era-edta.org/ 
eureca-m_publications.htm).
The clinical research questions to be faced 
are numerous and the WG agreed that at this 
stage it is fundamental to identify research 
priorities. For this reason members of the 
Board of EURECA-m met twice in 2010 to 
delineate concrete plans for research initia-
tives and for scoping questions to be shared 
with EURECA-m members and interested 
investigators and clinicians. This Supple-
ment of Kidney International is the result of 
the joint effort of the EURECA-m Board. We 
hope that the doubts and questions listed in 
these manuscripts may serve as a stimulus for 
channeling research into priority themes and 
as a starting point to frankly debate the many 
intriguing problems posed by this fascinating 
research area.
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